A UCLA expert in Oklahoma’s landmark case against Johnson & Johnson claimed that doctors had effective tools to identify addiction risks in patients – but faced tough cross-examination about their effectiveness.
A UCLA expert in Oklahoma’s landmark case against Johnson & Johnson claimed that doctors had effective tools to identify addiction risks in patients – but faced tough cross-examination about their effectiveness.